Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial

Introduction: Individuals who enroll in intensive behavioral therapy (IBT) programs are asked to make several lifestyle changes simultaneously. However, few studies have examined the relative effects of adherence to different treatment components on weight loss. Objective: This secondary analysis of the SCALE IBT trial assessed adherence to the medication regimen, dietary self-monitoring, and physical activity recommendations and their relative contributions to weight change in individuals with obesity who were provided with IBT combined with either liraglutide 3.0 mg or placebo. Methods: SCALE IBT was a double-blinded, multicenter, randomized controlled trial comparing 56-week weight losses in individuals with obesity who received liraglutide 3.0 mg (n = 142) or placebo (n = 140), as an adjunct to IBT. Adherence to dietary self-monitoring, physical activity, and medication usage (liraglutide or placebo) were measured during the 56-week treatment period. A regression model was used to estimate the relative contribution of adherence to each treatment component to weight loss at week 56. Results: The proportion of individuals who adhered to each intervention component decreased over time. Compared with non-adherence, complete adherence to dietary self-monitoring and physical activity recommendations were associated with estimated weight changes of −7.2% (95% CI –10.4 to –4.0; p < 0.0001) and –2.0% (95% CI –3.2 to –0.8; p = 0.0009), respectively. Complete adherence to liraglutide predicted an additional weight loss of –6.5% (95% CI –10.2 to –2.9; p = 0.0005) relative to individuals who did not adhere to the medication regimen, while adherence to placebo did not have a statistically significant effect on weight loss (p = 0.33). Conclusions: High adherence to dietary self-monitoring and use of liraglutide 3.0 mg was associated with clinically relevant weight loss with IBT and adjunctive pharmacotherapy. The effect of adherence to physical activity was significant but smaller.

[1]  T. Wadden,et al.  Measures of adherence as predictors of early and total weight loss with intensive behavioral therapy for obesity combined with liraglutide 3.0 mg. , 2020, Behaviour research and therapy.

[2]  T. Wadden,et al.  Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial , 2020, Obesity.

[3]  T. Wadden,et al.  Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial , 2018, Obesity.

[4]  B. Lucke-Wold,et al.  The Effect of Adherence to Dietary Tracking on Weight Loss: Using HLM to Model Weight Loss over Time , 2017, Journal of diabetes research.

[5]  T. Wadden,et al.  Intensive Lifestyle Intervention for Obesity: Principles, Practices, and Results. , 2017, Gastroenterology.

[6]  A. Garber,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  M. Camilleri,et al.  Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. , 2016, JAMA.

[8]  M. Perri,et al.  The role of self-monitoring in the maintenance of weight loss success. , 2016, Eating behaviors.

[9]  Janusz Wnek,et al.  2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults , 2013, Circulation.

[10]  T. Wadden,et al.  Lifestyle Modification for Obesity: New Developments in Diet, Physical Activity, and Behavior Therapy , 2012, Circulation.

[11]  Jing Wang,et al.  Physical activity self-monitoring and weight loss: 6-month results of the SMART trial. , 2011, Medicine and science in sports and exercise.

[12]  M. Sevick,et al.  The Effect of Electronic Self‐Monitoring on Weight Loss and Dietary Intake: A Randomized Behavioral Weight Loss Trial , 2011, Obesity.

[13]  A. Tremblay,et al.  Physical Activity Plays an Important Role in Body Weight Regulation , 2010, Journal of obesity.

[14]  C. Champagne,et al.  Weight loss during the intensive intervention phase of the weight-loss maintenance trial. , 2008, American journal of preventive medicine.

[15]  Amy D. Otto,et al.  Comparison of techniques for self-monitoring eating and exercise behaviors on weight loss in a correspondence-based intervention. , 2007, Journal of the American Dietetic Association.

[16]  T. Wadden,et al.  Randomized trial of lifestyle modification and pharmacotherapy for obesity. , 2005, The New England journal of medicine.

[17]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[18]  R. Ness-Abramof,et al.  A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice , 2012 .

[19]  L. Burke,et al.  Adherence to a behavioral weight loss treatment program enhances weight loss and improvements in biomarkers , 2009 .